Format

Send to

Choose Destination
Am J Obstet Gynecol. 2010 Jun;202(6):568.e1-6. doi: 10.1016/j.ajog.2010.01.064. Epub 2010 Mar 15.

Peripartum metabolic control in gestational diabetes.

Author information

1
Department of Endocrinology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain. 94066@imas.imim.es

Abstract

OBJECTIVE:

We sought to evaluate intrapartum metabolic control in gestational diabetes mellitus (GDM) patients and maternal factors influencing intrapartum glycemic control and neonatal hypoglycemia risk.

STUDY DESIGN:

A prospective observational study included 129 women with GDM admitted for delivery. Data collected included maternal intrapartum capillary blood glucose (CBG) and ketonemia, use of insulin, and neonatal hypoglycemia.

RESULTS:

In all, 86% of maternal intrapartum CBG values fell within target range (3.3-7.2 mmol/L) without need for insulin use. There were no cases of maternal hypoglycemia or severe ketosis. Intrapartum CBG >7.2 mmol/L was associated with third-trimester glycated hemoglobin (P = .02) and lack of endocrinologic follow-up (P = .04). Risk of neonatal hypoglycemia was related with pregnancy insulin use compared with dietary control (60.5% vs 29.5%; P = .02).

CONCLUSION:

Peripartum metabolic control in GDM patients was achieved without insulin in most cases. Intrapartum glycemic control was related with third-trimester glycated hemoglobin and with no endocrinologic follow-up. Neonatal hypoglycemia was associated with insulin use during pregnancy.

PMID:
20231009
DOI:
10.1016/j.ajog.2010.01.064
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center